Predicting antibiotic resistance in complex protein targets using alchemical free energy methods

J Comput Chem. 2022 Oct 5;43(26):1771-1782. doi: 10.1002/jcc.26979. Epub 2022 Aug 25.

Abstract

Drug resistant Mycobacterium tuberculosis, which mostly results from single nucleotide polymorphisms in antibiotic target genes, poses a major threat to tuberculosis treatment outcomes. Relative binding free energy (RBFE) calculations can rapidly predict the effects of mutations, but this approach has not been tested on large, complex proteins. We use RBFE calculations to predict the effects of M. tuberculosis RNA polymerase and DNA gyrase mutations on rifampicin and moxifloxacin susceptibility respectively. These mutations encompass a range of amino acid substitutions with known effects and include large steric perturbations and charged moieties. We find that moderate numbers (n = 3-15) of short RBFE calculations can predict resistance in cases where the mutation results in a large change in the binding free energy. We show that the method lacks discrimination in cases with either a small change in energy or that involve charged amino acids, and we investigate how these calculation errors may be decreased.

Keywords: alchemical free energy methods; antibiotic resistance; molecular dynamics; relative binding free energy calculations; tuberculosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • DNA Gyrase / genetics
  • DNA Gyrase / metabolism
  • DNA Gyrase / pharmacology
  • Drug Resistance, Microbial
  • Humans
  • Moxifloxacin / pharmacology
  • Moxifloxacin / therapeutic use
  • Mutation
  • Mycobacterium tuberculosis* / genetics
  • Mycobacterium tuberculosis* / metabolism
  • Tuberculosis* / drug therapy
  • Tuberculosis* / microbiology

Substances

  • DNA Gyrase
  • Moxifloxacin